ACHE and Alzheimer disease: Currently, acetylcholinesterase (AChE) inhibitors are the dominant class of approved drugs to treat AD, and therefore, much effort has been devoted to the identification of novel natural compounds that are able to inhibit AChE as potential drugs for the treatment of this disease [26,27,28].